NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
25 hedge funds and large institutions have $513K invested in InVivo Therapeutics Holdings Corp in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$324K |
| 2 |
WS
2
Wedbush Securities
Los Angeles,
California
|
$12K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$24K |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3K |
Top Sellers
| 1 |
CH
1
CVI Holdings
Wilmington,
Delaware
|
$0 |
| 2 |
MAM
2
Meeder Asset Management
Dublin,
Ohio
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
LTFS
26
Ladenburg Thalmann Financial Services
Miami,
Florida
| $0 | 181 | – | – |
|
|
AIM
27
Advantage Investment Management
Cedar Rapids,
Iowa
| $0 | 40 | – | – |
|
|
VFA
28
Valeo Financial Advisors
Carmel,
Indiana
| $0 | 454 | – | – |
|
29
JPMorgan Chase & Co
New York
| $0 | 30 | – | – |
|
|
TF
30
TimeScale Financial
Danvers,
Massachusetts
| $0 | 5 | +5 | New |
|